Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitelvpcapital.com
Phone4153999880
EmailLaTonya@LVPcapita...
Employees7
Founded2001
DescriptionEarly stage healthcare

Funds

Offices

San Francisco, USA
One Embarcadero Center
Suite 4050
San Francisco, CA, 94111
USA

People

Founder
Partner
Partner
Partner
Venture Partner
Venture Consultant

Tags

Latterell Venture Partners

Latterell Venture Partners invests in early stage healthcare companies with innovative technologies, large market opportunities, and passionate entrepreneurs. We offer a unique blend of venture capital, entrepreneurial, technical, clinical and collaborative skills which enable us to help entrepreneurs create highly successful new startups. LVP is committed to building a portfolio of outstanding biotechnology and medical device companies which produce excellent returns for our limited partners while providing major new disease treatments to help patients worldwide.

Recent Milestones

Investments

Company Date Round Size Participants
Naurex 12/2012Series B$38M7
Neuraltus Pharmaceuticals 4/2012Venture Round$1.5M2
HemaQuest Pharmaceuticals 3/2012Series B$13M5
Pulmonx 1/2012Private Equity$10M5
Neuraltus Pharmaceuticals 1/2012Series B$9.6M3
Transcend Medical 1/2012Series B$16M9
Inova Labs 11/2011Series B$3.1M1
Naurex 5/2011Series A$18M6
CellBiosciences 10/2010Series F$20M8
Femta Pharmaceuticals 10/2010Series A$22M1
TetraLogic Pharmaceuticals 8/2010Series C$32M8
Calistoga Pharmaceuticals 6/2010Series C$40M6
Pulmonx 3/2010Series C$32M7
Femta Pharmaceuticals 7/2009Venture Round$1M1
Transcend Medical 6/2009Series B$35M6
CellBiosciences 4/2009Series C$10M7
Neuraltus Pharmaceuticals 3/2009Series A$17M3
Pathway Medical Technologies 3/2009Series D$42.5M5
OncoMed Pharmaceuticals 11/2008Series B$154M8
Talima Therapeutics 5/2007Series B$19M3
Pulmonx 5/2007Series B$20M4
Ovalis 1/2007Series B$6.6M3
CellBiosciences 1/2006Series B$27M8

Videos

Sources

  1. Naurex Completes $38 Million Series B Financing (fiercebiotech.com) [edit]
  2. VC Funding: Q2 2012 source [edit]
  3. HemaQuest Pharmaceuticals Raises $13 Million in Series B Extension Financing (hemaquest.com) [edit]
  4. Pulmonx Raises US$10 Million In Series D Financing (researchviews.com) [edit]
  5. Neuraltus Pharmaceuticals, Inc.: Series B $9.6M (onbiovc.com) [edit]
  6. Transcend Medical, Inc.: Series B $16M (onbiovc.com) [edit]
  7. SEC (sec.gov) [edit]
  8. Naurex raises $18M for Ph2 depression program (fiercebiotech.com) [edit]
  9. Cell Biosciences Nabs $20M (xconomy.com) [edit]
  10. Femta Pharmaceuticals, Inc.: Series A $22M (onbiovc.com) [edit]
  11. TetraLogic nabs $32M round for lead cancer therapy Read more: TetraLogic nabs $32M round for lead cancer therapy (fiercebiotech.com) [edit]
  12. Calistoga Pharmaceuticals Raises $40 Million in Series C Financing (calistogapharma.com) [edit]
  13. Pulmonx, Inc.: Series C $32M (onbiovc.com) [edit]
  14. Femta Pharmaceuticals Raises $1M (socaltech.com) [edit]
  15. Transcend Medical pockets $35M in VC (fiercebiotech.com) [edit]
  16. Cell Biosciences Raises $10 Million (pehub.com) [edit]
  17. Neuraltus Pharmaceuticals Raises $17 Million Series A Funding (neuraltus.com) [edit]
  18. Pathway Medical lands generous $40M to treat arterial disease (venturebeat.com) [edit]
  19. OncoMed Pharmaceuticals, Inc. Completes $154 Million Series B Financing (biospace.com) [edit]
  20. Talima Therapeutics raises $19M for site-specific drugs (venturebeat.com) [edit]
  21. Lung-device maker Pulmonx draws in $20M (venturebeat.com) [edit]
  22. Ovalis, Inc.: Series B $6.6M (onbiovc.com) [edit]
  23. Bio-Medicine (bio-medicine.org) [edit]
Edit This Page
Last Edited 3/17/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy